| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
INSERM U-248, 10, Avenue de Verdun, 75010 Paris, France
The rab2 gene product belongs to the rab branch of the ras-related GTP-binding protein family. The rab2 gene mRNA analysis in 70 tumor samples from various origins showed no obvious difference between malignant tissues and their normal counterparts. However, an over-expression has been observed at the RNA or protein levels in peripheral blood mononuclear cells from the nine patients with Sézary syndromes studied. Subsequent investigations in mycosis fungoides and solid tumor patients allowed us to link these high protein levels to immune reactive rather than to malignant cells. Circulating monocyte and lymphocyte populations from cancer patients are under analysis to correlate the Rab2 protein overexpression to a peculiar subset of cells.
1 This work was supported by the Institut National de la Santé et de la Recherche Médicale and by a grant from the Ligue Nationale Française contre le Cancer.
2 To whom requests for reprints should be addressed.
Received 9/ 3/91. Accepted 3/19/92.
This article has been cited by other articles:
![]() |
M. Eileen Dolan, B. L. McRae, E. Ferries-Rowe, M. Belanich, G. A. van Seventer, J. Guitart, D. Pezen, T. M. Kuzel, and D. B. Yarosh O6-Alkylguanine-DNA Alkyltransferase in Cutaneous T-Cell Lymphoma: Implications for Treatment with Alkylating Agents Clin. Cancer Res., August 1, 1999; 5(8): 2059 - 2064. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |